Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways

SIMPLE SUMMARY: High-grade bone and soft tissue sarcomas are known for high recurrence and low survival rates. New drug development is costly and time-consuming. Instead, new combinations of existing drugs may offer novel anticancer strategies. We previously demonstrated that the combination of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Koichi, Asanuma, Kunihiro, Okamoto, Takayuki, Iino, Takahiro, Hagi, Tomohito, Nakamura, Tomoki, Sudo, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177427/
https://www.ncbi.nlm.nih.gov/pubmed/37173935
http://dx.doi.org/10.3390/cancers15092468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177427/
https://www.ncbi.nlm.nih.gov/pubmed/37173935
http://dx.doi.org/10.3390/cancers15092468

Ejemplares similares